Abstract
BACKGROUND: Surveillance imaging of previously unruptured, coiled aneurysms remains routine even though reports of rupture of these aneurysms are extremely rare.
PURPOSE: We performed meta-analysis to examine long-term rupture risk over ≥1-year follow-up duration in patients with unruptured intracranial aneurysm who underwent endovascular therapy.
DATA SOURCES: Multiple databases were searched for relevant publications between 1995 and 2018.
STUDY SELECTION: Studies reporting outcome of long-term rupture risk over ≥1-year follow-up in treated patients with unruptured intracranial aneurysms were included.
DATA ANALYSIS: Random effects meta-analysis was used, and results were expressed as long-term rupture rate per 100 patient-year with respective 95% CIs. For ruptured aneurysms during follow-up, data were collected on size and completeness of initial Treatment.
DATA SYNTHESIS: Twenty-four studies were identified. Among 4842 patients with a mean follow-up duration of 3.2 years, a total of 12 patients (0.25%) experienced rupture of previous unruptured intracranial aneurysms after endovascular treatment. Nine of these 12 patients harbored aneurysms that were large, incompletely treated, or both. A total of 2 anterior circulation, small, completely coiled aneurysms subsequently ruptured. The long-term rupture rate per 100 patient-year for unruptured intracranial aneurysms treated with endovascular therapy was 0.48 (95% CI, 0.45–0.51). Retreatment was carried out in 236 (4.9%) of these 4842 patients.
LIMITATIONS: A limitation of the study is that a lack of systematic nature of follow-up and mean follow-up duration of 3.2 years are not sufficient to make general recommendations about aneurysm followup paradigms.
CONCLUSIONS: Given a 5% retreatment rate, postcoil embolization spontaneous rupture of previously unruptured, small- and medium-sized, well-treated aneurysms is exceedingly rare.
ABBREVIATIONS:
- CI
- confidence interval
- PRISMA
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses
- PY
- patient-year
- UIA
- unruptured intracranial aneurysm
Footnotes
Grant support: This research was supported by AHA postdoctoral fellowship award # 19POST34381068 and NIH grant # NS076491.
Disclosures: Asim Rizvi—RELATED: Grant: 19POST34381068, Comments: American Heart Association Grant, AHA postdoctoral fellowship award*; Support for Travel to Meetings for the Study or Other Purposes: 19POST34381068, Comments: American Heart Association Grant, AHA postdoctoral fellowship award*; Other: NS076491, Comments: NIH grant*; UNRELATED: Grants/Grants Pending: 19POST34381068, Comments: This research was supported by AHA postdoctoral fellowship award # 19POST34381068 and NIH grant # NS076491.* Seyed Mohammad Seyedsaadat—RELATED: Grant: AHA 2 years postdoctoral research fellowship. Ram Kadirvel—RELATED: Grant: NIH, Comments: R01 NS076491 and R43 NS110114; Other: Cerenovus, Insera Therapeutics LLC, Marblehead Medical LLC, Microvention Inc, MIVI Neuroscience Inc, Neurogami Medical Inc, Triticum Inc, Comments: Research contracts; UNRELATED: Stock/Stock Options: Neurosigma Inc.* David Kallmes—UNRELATED: Grants/Grants Pending: Medtronic, Microvention, NeuroSigma, Neurogami, General Electric, Comments: Research support*; Stock/Stock Options: Superior Medical Experts, Comments: Founder/stockholder. *Money paid to institution.
- © 2020 by American Journal of Neuroradiology
Indicates open access to non-subscribers at www.ajnr.org